Nexavar impresses in clinical trials

(Reuters) UPDATED 2009-09-21

Researchers say the experimental breast cancer drug Nexavar has shown positive effects in new clinical trials. Patients who received Nexavar along with the chemo drug Xeloda had a 74 percent improvement in the amount of time they lived without a disease progression, researchers found. The drug is used around the world to treat liver and kidney cancer, and experts say there will be further clinical trials on its use as a breast cancer medication. Read full story >

See all Breast Cancer News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyBreastCancerNetwork.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.

Sign in

MyBreastCancerNetwork.com

Nexavar impresses in clinical trials

People who read this also read...

What the community is saying...

Making Sense of The New Mammography Recommendations

Angi